Inicio › Cáncer de ovario › Pensilvania › Philadelphia
Ensayos clínicos de Cáncer de ovario en Philadelphia, PA
45 estudios para Cáncer de ovario buscan participantes en centros de Philadelphia y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
ReclutandoFase 2
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612, Philadelphia
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
ReclutandoFase 3
- Alliance Cancer Specialists - Abington Hematology Oncology Associates - Horsham, Horsham · A 16 mi de distancia
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
ReclutandoFase 3
- Hospital of the University of Pennsylvania ( Site 0071), Philadelphia
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
ReclutandoFase 2
- Penn Medicine University of Pennsylvania Health System /ID# 277963, Philadelphia
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- y 4 más
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
ReclutandoFase 2/3
- Thomas Jefferson University Hospital, Philadelphia
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutandoFase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
Reclutando
- University of Pennsylvania, Philadelphia
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ReclutandoFase 2
- Site 0232 - University of Pennsylvania, Philadelphia
- Site 0178 - Thomas Jefferson University, Philadelphia
Study of AVZO-021 in Patients With Advanced Solid Tumors
ReclutandoFase 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
DESTINY-PANTUMOUR04
ReclutandoEstudio observacional
- Research Site, Philadelphia
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
ReclutandoFase 1/2
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ReclutandoFase 3
- University of Pennsylvania Hospital, Philadelphia
- Jefferson Health Honickman Center, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · A 13 mi de distancia
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
ReclutandoFase 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
Reclutando
- Fox Chase Cancer Center - Philadelphia, Philadelphia
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
ReclutandoFase 1/2
- University of Pennsylvania, Philadelphia
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
ReclutandoFase 3
- Lankenau Medical Center, Wynnewood · A 7 mi de distancia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
ReclutandoEstudio observacional
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
ReclutandoFase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
ReclutandoFase 1
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
ReclutandoFase 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
ReclutandoFase 1
- SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia
The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry
ReclutandoEstudio observacional
- ACPMP, Springfield · A 8 mi de distancia
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
ReclutandoFase 3
- Site 0109, Philadelphia
- Site 0113, Philadelphia
- Site 0114, Willow Grove · A 13 mi de distancia
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
ReclutandoFase 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- y 5 más
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Reclutando
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Lankenau Medical Center, Wynnewood · A 7 mi de distancia
- y 5 más
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ReclutandoFase 2/3
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
ReclutandoFase 2
- Thomas Jefferson University, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Investigative Site #109, Philadelphia
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
ReclutandoFase 2
- University of Pennsylvania Health System, Perelman Center for Advanced Medicine, Philadelphia
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
ReclutandoFase 1
- University of Pennsylvania, Philadelphia
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
ReclutandoFase 1
- Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
ReclutandoFase 1/2
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
ReclutandoFase 3
- Lankenau Medical Center/Mainline Medical Center, Wynnewood · A 7 mi de distancia
- Jefferson Abington Hospital, Abington · A 12 mi de distancia
- Asplundh Cancer Pavilion, Willow Grove · A 13 mi de distancia
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Reclutando
- Hospital of the University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ReclutandoFase 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ReclutandoFase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Healthy Volunteers Study
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
ReclutandoFase 2
- University of Pennsylvania, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Philadelphia
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
ReclutandoFase 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
ReclutandoEstudio observacional
- Gynecologic Oncology Group, Philadelphia
Más información sobre Cáncer de ovario en MedlinePlus
Ensayos de Cáncer de ovario en otras ciudades
- Houston, TX89 estudios
- New York City, NY70 estudios
- Boston, MA61 estudios
- Los Angeles, CA50 estudios
- Nashville, TN49 estudios
- Arlington, VA46 estudios
- Columbus, OH39 estudios
- St. Louis, MO38 estudios
- Chicago, IL36 estudios
- Pittsburgh, PA31 estudios
- San Antonio, TX31 estudios
- Seattle, WA30 estudios
Otros estudios en Philadelphia
- Cáncer (todos los tipos)59 estudios
- Cáncer de seno57 estudios
- Cáncer de pulmón de células no pequeñas51 estudios
- Cáncer metastásico46 estudios
- Cáncer del colon y del recto44 estudios
- Cáncer de próstata44 estudios
- Cáncer de pulmón36 estudios
- Leucemia mielógena aguda34 estudios
- Fallo cardíaco31 estudios
- Cáncer de endometrio28 estudios
- Cáncer de páncreas26 estudios
- Depresión26 estudios
De ClinicalTrials.gov, datos obtenidos el 7 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.